15-Deoxy-Δ 12,14-prostaglandin J 2 attenuates the biological activities of monocyte/macrophage cell lines

European Journal of Cell Biology

Volumn 91, Issue 8, 2012, Pages 654-661

  Liu, Xin ^a   Yu, Hao ^a   Yang, Lin ^a   Li, Changyong ^a   Li, Liying ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

15 Deoxy 12,14 prostaglandin J 2; 15d PGJ 2; Cytokines; IL 6; LPS; MCP 1; Monocytes macrophages; NAC; Peroxisome proliferator activated receptor gamma; Phagocytosis; PPAR ; Proliferation; Reactive oxygen species; ROS; TGF 1; TNF

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 CHLORO 5 NITROBENZANILIDE; CIGLITAZONE; CYTOKINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA1; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECT; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLCYSTEINE; ANILIDES; ANIMALS; CELL LINE; CELL PROLIFERATION; CHEMOKINE CCL2; CHROMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MONOCYTES; OXIDATIVE STRESS; PHAGOCYTOSIS; PPAR GAMMA; PROSTAGLANDIN D2; REACTIVE OXYGEN SPECIES; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861653230     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2012.03.004     Document Type: Article

References (32)

1. Adler V., Yin Z.M., Tew K.D., Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 1999, 18:6104-6111.
2. Alves C.F., de Melo N.F.S., Fraceto L.F., de Araujo D.R., Napimoga M.H. Effects of 15d-PGJ(2)-loaded poly(d,l-lactide-co-glycolide) nanocapsules on inflammation. British Journal of Pharmacology 2011, 162:623-632.
3. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., Evans R.M. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nature Medicine 2001, 7:48-52.
4. Cuzzocrea S., Wayman N.S., Mazzon E., Dugo L., Di Paola R., Serraino I., Britti D., Chatterjee P.K., Caputi A.P., Thiemermann C. The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation. Molecular Pharmacology 2002, 61:997-1007.
5. Diab A., Deng C.S., Smith J.D., Hussain R.Z., Phanavanh B., Lovett-Racke A.E., Drew P.D., Racke M.K. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. Journal of Immunology 2002, 168:2508-2515.
6. Diers A.R., Dranka B.P., Ricart K.C., Oh J.Y., Johnson M.S., Zhou F., Pallero M.A., Bodenstine T.M., Murphy-Ullrich J.E., Welch D.R., Landar A. Modulation of mammary cancer cell migration by 15-deoxy-Delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy. Biochemical Journal 2010, 430:69-78.
7. Guyton K., Bond R., Reilly C., Gilkeson G., Halushka P., Cook J. Differential effects of 15-deoxy-Delta(12,14)-prostaglandin J(2) and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation. Journal of Leukocyte Biology 2001, 69:631-638.
8. Hao G.H., Niu X.L., Gao D.F., Wei J., Wang N.P. Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts. British Journal of Pharmacology 2008, 153:1409-1419.
9. Hirai H., Tanaka K., Yoshie O., Ogawa K., Kenmotsu K., Takamori Y., Ichimasa M., Sugamura K., Nakamura M., Takano S., Nagata K. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. Journal of Experimental Medicine 2001, 193:255-261.
10. Hisamatsu T., Ogata H., Hibi T. Innate immunity in inflammatory bowel disease: state of the art. Current Opinion in Gastroenterology 2008, 24:448-454.
11. Jiang C.Y., Ting A.T., Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391:82-86.
12. Kaplan J.M., Cook J.A., Hake P.W., O'Connor M., Burroughs T.J., Zingarelli A. 15-Deoxy Delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock. Shock 2005, 24:59-65.
13. Kim E.H., Surh Y.J. 15-Deoxy-Delta(12,14)-prostaglandin J(2) as a potential endogenous regulator of redox-sensitive transcription factors. Biochemical Pharmacology 2006, 72:1516-1528.
14. Lee C.M., Yeoh G.C., Olynyk J.K. Differential effects of gadolinium chloride on Kupffer cells in vivo and in vitro. International Journal of Biochemistry & Cell Biology 2004, 36:481-488.
15. Li L.Y., Grenard P., Van Nhieu J.T., Julien B., Mallat A., Habib A., Lotersztajn S. Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts. Gastroenterology 2003, 125:460-468.
16. Li L.Y., Tao J.C., Davaille J., Feral C., Mallat A., Rieusset J., Vidal H., Lotersztajn S. 15-Deoxy-Delta(12,14)-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts-a pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors. Journal of Biological Chemistry 2001, 276:38152-38158.
17. Liu X.H., Yue S., Li C.Y., Yang L., You H., Li L.Y. Essential roles of sphingosine 1-phosphate receptor types 1 and 3 in human hepatic stellate cells motility and activation. Journal of Cellular Physiology 2011, 226:2370-2377.
18. Marx N., Sukhova G., Murphy C., Libby P., Plutzky J. Macrophages in human atheroma contain PPAR gamma-differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPAR gamma) expression and reduction of MMP-9 activity through PPAR gamma activation in mononuclear phagocytes in vitro. American Journal of Pathology 1998, 153:17-23.
19. Napimoga M.H., Vieira S.M., Dal-Secco D., Freitas A., Souto F.O., Mestriner F.L., Alves J.C., Grespan R., Kawai T., Ferreira S.H., Cunha F.Q. Peroxisome proliferator-activated receptor-gamma ligand,15-deoxy-Delta A(12,14)-prostaglandin J(2), reduces neutrophil migration via a nitric oxide pathway. Journal of Immunology 2008, 180:609-617.
20. Ricote M., Huang J.T., Welch J.S., Glass C.K. The peroxisome proliferator-activated receptor gamma (PPAR gamma) as a regulator of monocyte/macrophage function. Journal of Leukocyte Biology 1999, 66:733-739.
21. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391:79-82.
22. Schenk M., Mueller C. Adaptations of intestinal macrophages to an antigen-rich environment. Seminars in Immunology 2007, 19:84-93.
23. Scher J.U., Pillinger M.H. 15d-PGJ(2): the anti-inflammatory prostaglandin?. Clinical Immunology 2005, 114:100-109.
24. Su C.G., Wen X.M., Bailey S.T., Jiang W., Rangwala S.M., Keilbaugh S.A., Flanigan A., Murthy S., Lazar M.A., Wu G.D. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. Journal of Clinical Investigation 1999, 104:383-389.
25. Thieringer R., Fenyk-Melody J.E., Le Grand C.B., Shelton B.A., Detmers P.A., Somers E.P., Carbin L., Moller D.E., Wright S.D., Berger J. Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo. Journal of Immunology 2000, 164:1046-1054.
26. Tsai J.S., Chen C.Y., Chen Y.L., Chuang L.M. Rosiglitazone inhibits monocyte/macrophage adhesion through de novo adiponectin production in human monocytes. Journal of Cellular Biochemistry 2010, 110:1410-1419.
27. Valledor A.F., Ricote M. Nuclear receptor signaling in macrophages. Biochemical Pharmacology 2004, 67:201-212.
28. Wang J.J., Mak O.T. Induction of apoptosis by 15d-PGJ(2) via ROS formation: an alternative pathway without PPAR gamma activation in non-small cell lung carcinoma A549 cells. Prostaglandins & Other Lipid Mediators 2011, 94:104-111.
29. Zang C.B., Liu H.Y., Posch M.G., Waechter M., Facklam M., Fenner M.H., Ruthardt M., Possinger K., Koeffler H.P., Elstner E. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia. Leukemia Research 2004, 28:387-397.
30. Zhang X., Wang J.M., Gong W.H., Mukaida N., Young H.A. Differential regulation of chemokine gene expression by 15-deoxy-Delta(12,14) prostaglandin J(2). Journal of Immunology 2001, 166:7104-7111.
31. Zhou L., Braat H., Faber K.N., Dijkstra G., Peppelenbosch M.P. Monocytes and their pathophysiological role in Crohn's disease. Cellular and Molecular Life Sciences 2009, 66:192-202.
32. Zingarelli B., Sheehan M., Hake P.W., O'Connor M., Denenberg A., Cook J.A. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J(2) and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. Journal of Immunology 2003, 171:6827-6837.